News

Additionally, combined data from three other Phase III studies showed that RA patients who received Actemra had sustained improvements in signs and symptoms over nearly two years. Across

Lodotra is a proprietary programmed-release formulation of low-dose prednisone and has received regulatory approval in Europe for reduction in morning stiffness associated with rheumatoid arthritis (RA). Merck Serono

Kombiglyze XR is a once-a-day metformin extended-release (XR) plus dipeptidyl peptidase-4 (DPP-4) inhibitor combination tablet offering glycaemic control across glycosylated haemoglobin levels (HbA1c), fasting plasma glucose (FPG) and

Headquartered in Pleasanton, CA, IntegenX is a privately held company that designs, manufactures and markets automated DNA- and RNA-based sample preparation systems for life sciences, applied sciences and

Genesis Biopharma is developing its anti-CD55 antibody therapy to neutralize a key cancer defense mechanism that has been found to be over-expressed in more than 80% of solid

The agreement grants Nutrition 21 an exclusive license in the US and Canada for Coldizin, an ingredient combination, patented in the US and Europe, for enhancing upper-respiratory health.

Targacept has posted a net income of $2.49m for the third quarter 2010, or $0.08 per diluted share, compared to $1.33m, or $0.05 per diluted share, for the

Senesco president and CEO Leslie Browne said that they are pleased to receive this grant to support continued development of SNS01-T, company’s lead therapeutic candidate for the treatment

Fuhrer has over 12 years experience directing teams of scientists and technicians in large pharmaceutical companies, biotech organisations and CROs. Fuhrer has experience in therapeutic areas like anti-infectives,